“In atopic dermatitis, the itching can be horrific, and it can aggravate disease,” said co-corresponding author K. Frank Austen, MD, a senior physician in the Division of Allergy and Clinical Immunology at the Brigham.
Scientists pinpointed a key molecular player that could represent a new therapeutic target for intractable chronic itch.
Comments are closed.